AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Brainsway Ltd.

Regulatory Filings Jul 29, 2020

6701_rns_2020-07-29_d559334e-79ea-4765-a51a-753e613aa2cc.htm

Regulatory Filings

Open in Viewer

Opens in native device viewer

BrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020 false

���������� ��"� 2 380
BRAINSWAY LTD
Corporation no: 513890764 10767
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 29/07/2020
www.isa.gov.il www.tase.co.il Reference: 2020-02-074401 Time of broadcast: 14:57 14:57

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onBrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020

6K_BrainsWay_to_Report_Second_Quarter_2020_Financial_Results_and_Operational_Highlights_on_August_12_2020_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: BWAY Date of revision of form structure: 23/06/2020
Address: ����� 19 , ������� 91451   , Tel: 02-5813140 , Fax: 02-5812517
E-mail address: [email protected]   Company site: www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.